# A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients

> **NCT03773042** · PHASE2 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 64 (actual)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03773042
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03773042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03773042, "A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03773042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*